Make your money go further for just 25p per day

LiDCO Group plc (LID) – second profitable year for this exciting pharma company 

31/03/2015 · LiDCO Group plc (LID) 

LiDCO supplies minimally invasive and non-invasive hemodynamic equipment to hospitals, to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. LiDCO’s products enable the measurement, analysis, audit, training and sharing of real-time and historic hemodynamic data, in both critical care units and operating theatres.

Worldwide there are 240 million anaesthetic procedures performed per annum of which 24 million are high-risk surgeries. During the year a number of exciting studies that used LiDCO’s technology were published. These showed that LiDCO’s computer-based technology, developed at St Thomas’ Hospital in London, significantly reduce morbidity and complications, length of stay and overall costs associated with major surgery such as high-risk cancer surgery, cardiac surgery and post-surgical intensive care populations.

Today the Group announced…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on LiDCO Group plc

Coronavirus impact: 13 Oct - we aren’t impressed with the antics of some

13/10/2020 · Company Insights

It has taken a long time coming, but a developer of medical devices covered here, finally…


LiDCO Group plc (LID) – second profitable year for this exciting pharma company 

31/03/2015 · Company Insights
LiDCO supplies minimally invasive and non-invasive hemodynamic equipment to hospitals, to monitor the amount of blood…

More Company Insights

Elderly challenges | Demotion | Australian boost

21/11/2024 · Churchill China · CVS Group · Renold · Tracsis

Bonkers Bargains: poised to recover with a new CEO

20/11/2024 · James Cropper

Improving returns | Questionable business models

Sign-up to our free email updates

SIGN UP